Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*-Reference-Cited by-同舟云学术

Efficacy and safety of the monoclonal anti-tumor necrosis factor antibody F(ab′)2 fragment afelimomab in patients with severe sepsis and elevated interleukin-6 levels*

Published:2004-11 Issue:11 Volume:32 Page:2173-2182
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Panacek Edward A.,Marshall John C.,Albertson Timothy E.,Johnson David H.,Johnson Steven,MacArthur Rodger D.,Miller Mark,Barchuk William T.,Fischkoff Steven,Kaul Martin,Teoh Leah,Van Meter Lori,Daum Lothar,Lemeshow Stanley,Hicklin Gregory,Doig Christopher

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference47 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. Treating Patients with Severe Sepsis

3. Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

4. Circulating Interleukin-1 and Tumor Necrosis Factor in Septic Shock and Experimental Endotoxin Fever

5. Detection of Circulating Tumor Necrosis Factor after Endotoxin Administration

Cited by 326 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing Patient Selection in Sepsis Clinical Trials Design Through an AI Enrichment Strategy: Algorithm Development and Validation;Journal of Medical Internet Research;2024-09-04

2. Evolving Paradigms in Sepsis Management: A Narrative Review;Cells;2024-07-09

3. Role of Kynurenine and Its Derivatives in the Neuroimmune System;International Journal of Molecular Sciences;2024-06-28

4. Neuroimmune modulation by tryptophan derivatives in neurological and inflammatory disorders;European Journal of Cell Biology;2024-06

5. Towards personalized medicine: a scoping review of immunotherapy in sepsis;Critical Care;2024-05-28